SEAR vs Singapore: Hypertension: effective treatment coverage (controlled hypertension)
SEAR
13.3%
in 2019
Singapore
38.8%
in 2019
SEAR rank
13th
Singapore rank
11th
Hypertension: effective treatment coverage (controlled hypertension) over time
- SEAR
- Singapore
How they compare
Singapore currently reports 38.8% against 13.3% in SEAR, a difference of 25.5%.
That makes Singapore's figure about 2.9 times SEAR's.
Across all 30 years both countries report, Singapore has been ahead every year.
SEAR ranks 13th and Singapore ranks 11th of 17 groups.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | SEAR | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.6% | 6.8% | 4.2% | Singapore |
| 2000s | 5.7% | 16.4% | 10.8% | Singapore |
| 2010s | 10.7% | 32.1% | 21.4% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension: effective treatment coverage (controlled hypertension), SEAR or Singapore?
- Singapore, at 38.8% against 13.3% in SEAR as of 2019.
- What is the difference in hypertension: effective treatment coverage (controlled hypertension) between SEAR and Singapore?
- 25.5%, with Singapore ahead.
- How many years of comparable data are there for SEAR and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do SEAR and Singapore rank globally for hypertension: effective treatment coverage (controlled hypertension)?
- SEAR ranks 13th and Singapore ranks 11th of 17 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.